Reverse transcriptase-polymerase chain reaction based quantification of the combined MDS-EVI1/EVI1 gene in acute myeloid leukemia [1]

Leukemia and Lymphoma

Volumn 47, Issue 12, 2006, Pages 2645-2647

  Weisser, Martin ^a   Kern, Wolfgang ^b   Schoch, Claudia ^b   Tschulik, Claudia ^b   Hiddemann, Wolfgang ^a   Haferlach, Torsten ^b   Schnittger, Susanne ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b MLL MUNICH LEUKEMIA LABORATORY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEIN EVI1; PROTEIN MDS-EVI1;

ACUTE GRANULOCYTIC LEUKEMIA; BONE MARROW BIOPSY; CHROMOSOME 11Q; CHROMOSOME 3Q; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOGENETICS; EXON; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; LETTER; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BONE MARROW; BONE MARROW CELLS; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 3; DNA-BINDING PROTEINS; HUMANS; KARYOTYPING; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKOCYTES, MONONUCLEAR; MYELODYSPLASTIC SYNDROMES; ONCOGENE PROTEINS, FUSION; PROTO-ONCOGENES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 33845571021     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190600942561     Document Type: Letter

References (14)

1. Mitani, K. (2004) Molecular mechanisms of leukemogenesis by AML1/EVI1 Oncogene, 23, pp. 4263-4269.
2. Jolkowska, J and Witt, M. (2000) The EVI-1 gene - its role in pathogenesis of human leukemias Leuk Res, 24, pp. 553-558.
3. Morishita, K and Parganas, E and William, C and Whittaker, M and Drabkin, H and Oval, J and (1992) Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300 - 400 kilobases on chromosome band 3q26 Proc Natl Acad Sci USA, 89, pp. 3937-3941.
4. Russell, M and List, A and Greenberg, P and Woodward, S and Glinsmann, B and Parganas, E and (1994) Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations Blood, 84, pp. 1243-1248.
5. Barjesteh, van Waalwijk and van Doorn-Khosrovani, S and Erpelinck, C and van Putten, W and Valk, P and van der Poel-van de Luytgaarde, S and (2003) High EVI1 expression predicts poor survival in acute myeloid leukemia: A study of 319 de novo AML patients Blood, 101, pp. 837-845.
6. Langabeer, S and Rogers, J and Harrison, G and Wheatley, K and Walker, H and Bain, B and (2001) EVI1 expression in acute myeloid leukaemia Br J Haematol, 112, pp. 208-211.
7. Jaffe, E and Harris, N and Stein, H and Vardiman, J. (2001) World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press.
8. (1995) ISCN 1995. Guidelines for cancer cytogenetics. Supplement to an international system for human cytogenetic nomenclature. Basel: S. Karger.
9. Emig, M and Saussele, S and Wittor, H and Weisser, A and Reiter, A and Willer, A and (1999) Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCR Leukemia, 13, pp. 1825-1832.
10. Schnittger, S and Weisser, M and Schoch, C and Hiddemann, W and Haferlach, T and Kern, W. (2003) New score predicting for prognosis in PML-RARA+, AML1-ETO+, or CBFBMYH11+ acute myeloid leukemia based on quantification of fusion transcripts Blood, 102, pp. 2746-2755.
11. Buonamici, S and Ottaviani, E and Testoni, N and Montefusco, V and Visani, G and Bonifazi, F and (2002) Real-time quantitation of minimal residual disease in inv (16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state Blood, 99, pp. 443-449.
12. Marcucci, G and Caligiuri, M and Dohner, H and Archer, K and Schlenk, R and Dohner, K and (2001) Quantification of CBFbeta/MYH11 fusion transcript by real time RT-PCR in patients with INV(16) acute myeloid leukemia Leukemia, 15, pp. 1072-1080.
13. Weisser, M and Kern, W and Rauhut, S and Schoch, C and Hiddemann, W and Haferlach, T and Schnittger, S. (2005) Prognostic impact of RT-PCR-based quantification of WT1 gene expression during MRD monitoring of acute myeloid leukemia Leukemia, 19, pp. 1416-1423.
14. Garg, M and Moore, H and Tobal, K and Liu Yin, J. (2003) Prognostic significance of quantitative analysis of WT1 gene transcripts by competitive reverse transcription polymerase chain reaction in acute leukaemia Br J Haematol, 123, pp. 49-59.